A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK

Thorax

Volumn 57, Issue 9, 2002, Pages 810-816

  Drobniewski, Francis ^a   Eltringham, I ^a   Graham, C ^b   Magee, J G ^c   Smith, E G ^d   Watt, B ^e  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^e CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DNA FINGERPRINTING; FACTORIAL ANALYSIS; FEMALE; HAZARD ASSESSMENT; HUMAN; IMMUNE DEFICIENCY; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SPUTUM SMEAR; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUBERCULOSIS; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SPUTUM; SURVIVAL ANALYSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0036731710     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.9.810     Document Type: Article

References (29)

1. Epidemiology of tuberculosis in the world
2. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy
3. Global trends in resistance to antituberculosis drugs
4. Tuberculosis in England and Wales in 1993: Results of a national survey
5. Tuberculosis at the end of the 20th century in England and Wales: Results of a national survey in 1998
6. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999
7. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin
8. An outbreak of TB caused by multi-drug resistant tubercle bacilli among patients with HIV infection
9. Is death inevitable with multiresistant plus HIV infection?
10. Outcome of MDRTB patients, 1983-1993: Prolonged survival with appropriate therapy
11. Outcome of chemotherapy in 107 patients with pulmonary TB resistant to isoniazid arid rifampicin
12. Predictors and outcome of multidrug-resistant tuberculosis
13. Multidrug-resistant tuberculosis in patients without HIV infection
14. Mycobacterial speciation
15. Current laboratory methods for the diagnosis of tuberculosis
16. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis
17. A confidence interval for the median survival time
18. An outbreak of multi-drug resistant tuberculosis in a London teaching hospital
19. An outbreak of hospital acquired multidrug resistant tuberculosis
20. Outcome of multi-drug-resistant tuberculosis in France: A nationwide case control study
21. Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations of the Joint Tuberculosis Committee of the British Thoracic Society
22. Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations 1998
23. Bioavailability studies in man
24. First-line tuberculosis therapy and drug resistant Mycobacterium tuberculosis in prisons
25. Diagnosing MDRTB in Britain
26. A clinical, microbiological and economic analysis of a national UK service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis